Endocannabinoids and striatal function: implications for addiction-related behaviours

Por Moreira, Fabricio A., Jupp, Bianca, Belin, David, Dalley, Jeffrey W.
Publicado no Behav Pharmacol (2015)

In vivo evidence for a role of protein kinase C in peripheral nociceptive processing

Por Souza, Adriano L S, Moreira, Fabrício A, Almeida, Karine R, Bertollo, Caryne M, Costa, Karina A, Coelho, Márcio M
Publicado em 2002

Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

Por Casarotto, Plínio C, Terzian, Ana Luisa B, Aguiar, Daniele C, Zangrossi, Hélio, Guimarães, Francisco S, Wotjak, Carsten T, Moreira, Fabrício A
Publicado em 2012

Endocannabinoid System and Psychiatry: In Search of a Neurobiological Basis for Detrimental and Potential Therapeutic Effects

Por Marco, Eva M., García-Gutiérrez, María S., Bermúdez-Silva, Francisco-Javier, Moreira, Fabricio A., Guimarães, Francisco, Manzanares, Jorge, Viveros, María-Paz
Publicado em 2011

Orchestrated activation of mGluR5 and CB(1) promotes neuroprotection

Por Batista, Edleusa M. L., Doria, Juliana G., Ferreira-Vieira, Talita H., Alves-Silva, Juliana, Ferguson, Stephen S. G., Moreira, Fabricio A., Ribeiro, Fabiola M.
Publicado no Mol Brain (2016)

Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report

Por Bergamaschi, Mateus M., Queiroz, Regina H. C., Chagas, Marcos H. N., Linares, Ila M. P., Arrais, Kátia C., de Oliveira, Danielle C. G., Queiroz, Maria E., Nardi, Antonio E., Huestis, Marilyn A., Hallak, Jaime E. C., Zuardi, Antonio W., Moreira, Fabrício A., Crippa, José A. S.
Publicado no Hum Psychopharmacol (2013)